Literature DB >> 16835769

Differential ability of D1 and D2 dopamine receptor agonists to induce and modulate expression and reinstatement of cocaine place preference in rats.

Danielle L Graham1, Regis Hoppenot, April Hendryx, David W Self.   

Abstract

RATIONALE: D1-Like agonists are self-administered by drug-naive animals, whereas D2-like agonists reinstate cocaine-seeking behavior, but the rewarding and reinstating effects of D1- and D2-like agonists in pavlovian-based conditioned place preference are equivocal.
OBJECTIVE: To compare the ability of D1 and D2 agonists to produce conditioned place preference with their modulation of expression and reinstatement of an established cocaine place preference.
METHODS: Using an unbiased procedure, we measured the place preference induced by the D1 receptor agonist SKF 81297 and the D2/D3 receptor agonist quinpirole in drug-naive or cocaine-exposed rats. The rewarding effects of the D1 agonists SKF 82958, ABT-431, A-77636, and the D2/D3 receptor agonist 7-OH-DPAT were also tested. Additionally, we tested the ability of SKF 81297 and quinpirole to modulate expression and reinstatement of an established cocaine place preference.
RESULTS: The D1 receptor agonists SKF 81297, SKF 82958, and ABT-431 produced dose-dependent conditioned place preferences, whereas A-77636 produced only place aversion, and the D2/D3 agonists quinpirole and 7-OH-DPAT were without effect in drug naive rats. In cocaine-treated rats, SKF-81297-induced place preference was reduced, whereas quinpirole-induced place preference was revealed. Pretreatment using either D1 or D2/D3 agonists blocked expression of an established cocaine place preference, but only the D1 agonist SKF 81297 and cocaine dose-dependently reinstated an extinguished cocaine place preference, whereas the D2/D3 agonist quinpirole induced place aversion but failed to alter cocaine-induced reinstatement.
CONCLUSIONS: D1, but not D2/D3, agonists mediate rewarding effects and reinstatement of cocaine place preference, but the reinstating effects differ markedly from self-administration paradigms.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16835769     DOI: 10.1007/s00213-006-0473-5

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  66 in total

1.  Differential effects of dopamine antagonists on locomotor activity, conditioned activity and conditioned place preference induced by cocaine in rats.

Authors:  J U Adams; J M Careri; T R Efferen; J Rotrosen
Journal:  Behav Pharmacol       Date:  2001-12       Impact factor: 2.293

2.  Cocaine-induced conditioned place preference in mice: induction, extinction and reinstatement by related psychostimulants.

Authors:  Yossef Itzhak; Julio L Martin
Journal:  Neuropsychopharmacology       Date:  2002-01       Impact factor: 7.853

Review 3.  Measuring reward with the conditioned place preference paradigm: a comprehensive review of drug effects, recent progress and new issues.

Authors:  T M Tzschentke
Journal:  Prog Neurobiol       Date:  1998-12       Impact factor: 11.685

4.  Effects of dopamine D3 preferring compounds on conditioned place preference and intracranial self-stimulation in the rat.

Authors:  T Kling-Petersen; E Ljung; L Wollter; K Svensson
Journal:  J Neural Transm Gen Sect       Date:  1995

5.  Chronic repeated cocaine administration increases dopamine D1 receptor-mediated signal transduction.

Authors:  E M Unterwald; J Fillmore; M J Kreek
Journal:  Eur J Pharmacol       Date:  1996-12-27       Impact factor: 4.432

6.  Effects of binge pattern cocaine administration on dopamine D1 and D2 receptors in the rat brain: an in vivo study using positron emission tomography.

Authors:  H Tsukada; J Kreuter; C E Maggos; E M Unterwald; T Kakiuchi; S Nishiyama; M Futatsubashi; M J Kreek
Journal:  J Neurosci       Date:  1996-12-01       Impact factor: 6.167

7.  Morphine- and cocaine-induced conditioned place preference: effects of quinpirole and preclamol.

Authors:  T Kivastik; K Vuorikallas; T P Piepponen; A Zharkovsky; L Ahtee
Journal:  Pharmacol Biochem Behav       Date:  1996-06       Impact factor: 3.533

8.  The dopamine receptor agonist 7-OH-DPAT modulates the acquisition and expression of morphine-induced place preference.

Authors:  F Rodríguez De Fonseca; P Rubio; J L Martín-Calderón; S B Caine; G F Koob; M Navarro
Journal:  Eur J Pharmacol       Date:  1995-02-14       Impact factor: 4.432

9.  D1-receptor drugs and cocaine-seeking behavior: investigation of receptor mediation and behavioral disruption in rats.

Authors:  Andrea T Alleweireldt; Kenneth F Kirschner; Camille B Blake; Janet L Neisewander
Journal:  Psychopharmacology (Berl)       Date:  2003-01-09       Impact factor: 4.530

10.  Rapid dopamine signaling in the nucleus accumbens during contingent and noncontingent cocaine administration.

Authors:  Garret D Stuber; Mitchell F Roitman; Paul E M Phillips; Regina M Carelli; R Mark Wightman
Journal:  Neuropsychopharmacology       Date:  2005-05       Impact factor: 7.853

View more
  30 in total

1.  In vivo imaging identifies temporal signature of D1 and D2 medium spiny neurons in cocaine reward.

Authors:  Erin S Calipari; Rosemary C Bagot; Immanuel Purushothaman; Thomas J Davidson; Jordan T Yorgason; Catherine J Peña; Deena M Walker; Stephen T Pirpinias; Kevin G Guise; Charu Ramakrishnan; Karl Deisseroth; Eric J Nestler
Journal:  Proc Natl Acad Sci U S A       Date:  2016-02-01       Impact factor: 11.205

2.  Essential role of D1R in the regulation of mTOR complex1 signaling induced by cocaine.

Authors:  Laurie P Sutton; Marc G Caron
Journal:  Neuropharmacology       Date:  2015-08-24       Impact factor: 5.250

3.  Regional Heterogeneity of D2-Receptor Signaling in the Dorsal Striatum and Nucleus Accumbens.

Authors:  Pamela F Marcott; Sheng Gong; Prashant Donthamsetti; Steven G Grinnell; Melissa N Nelson; Amy H Newman; Lutz Birnbaumer; Kirill A Martemyanov; Jonathan A Javitch; Christopher P Ford
Journal:  Neuron       Date:  2018-04-12       Impact factor: 17.173

Review 4.  The neurobiology of social attachment: A comparative approach to behavioral, neuroanatomical, and neurochemical studies.

Authors:  Kimberly A Young; Yan Liu; Zuoxin Wang
Journal:  Comp Biochem Physiol C Toxicol Pharmacol       Date:  2008-03-02       Impact factor: 3.228

5.  Delayed extinction and stronger reinstatement of cocaine conditioned place preference in adolescent rats, compared to adults.

Authors:  Heather C Brenhouse; Susan L Andersen
Journal:  Behav Neurosci       Date:  2008-04       Impact factor: 1.912

Review 6.  Addiction: the clinical interface.

Authors:  D Nutt; A Lingford-Hughes
Journal:  Br J Pharmacol       Date:  2008-04-14       Impact factor: 8.739

7.  HDAC5 and Its Target Gene, Npas4, Function in the Nucleus Accumbens to Regulate Cocaine-Conditioned Behaviors.

Authors:  Makoto Taniguchi; Maria B Carreira; Yonatan A Cooper; Ana-Clara Bobadilla; Jasper A Heinsbroek; Nobuya Koike; Erin B Larson; Evan A Balmuth; Brandon W Hughes; Rachel D Penrod; Jaswinder Kumar; Laura N Smith; Daniel Guzman; Joseph S Takahashi; Tae-Kyung Kim; Peter W Kalivas; David W Self; Yingxi Lin; Christopher W Cowan
Journal:  Neuron       Date:  2017-09-27       Impact factor: 17.173

8.  Dopamine D1 receptor antagonist reduces stimulant-induced conditioned place preferences and dopamine receptor supersensitivity.

Authors:  Sun Mi Gu; Hye Jin Cha; So Woon Seo; Jin Tae Hong; Jaesuk Yun
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2019-08-01       Impact factor: 3.000

9.  Anatomically dissociable effects of dopamine D1 receptor agonists on reward and relief of withdrawal in morphine-dependent rats.

Authors:  Elena H Chartoff; Matthew F Barhight; Steve D Mague; Allison M Sawyer; William A Carlezon
Journal:  Psychopharmacology (Berl)       Date:  2009-01-16       Impact factor: 4.530

10.  Drug-induced activation of dopamine D(1) receptor signaling and inhibition of class I/II histone deacetylase induce chromatin remodeling in reward circuitry and modulate cocaine-related behaviors.

Authors:  Frederick A Schroeder; Krista L Penta; Anouch Matevossian; Sara R Jones; Christine Konradi; Andrew R Tapper; Schahram Akbarian
Journal:  Neuropsychopharmacology       Date:  2008-02-20       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.